Category: Event

FREE LIVE DEBATE “When can RWE be relied on to complement or replace evidence from RCTs to guide clinical decisions?” By leading Professors from Harvard, Oxford, London DATE: October 5, 2023, at 5pm CEST | 4pm UK time | 11am EST. OXON Epidemiology bring together for this live debate two leading proponents who believe that…
Read more

OUR FREE LIVE REAL WORLD MASTERCLASS SERIES WILL BE BACK AFTER THE SUMMER ‘How to ensure success and avoid pitfalls in Real World studies by Understanding Healthcare in Europe and Asia’ Dates: Restarting in September 2023 | Time: 5pm CET | 4pm UK | 11am EST | 8am PST OXON will be resuming the series…
Read more

RWE Masterclass 4: ‘Individualizing Benefit Risk’ Session 4: ‘Individualizing Benefit Risk’, will take place on Wednesday, 16 June 2021 at 5 pm CEST MORE INFORMATION|REGISTER HERE   SUMMARY: Conventional methods of benefit-risk overly focus on overall results; subgroups have limitations, and the relative importance of events may not be considered. Individualizing benefit-risk more precisely would…
Read more

RWE Masterclass 3: ‘Non-randomised comparative studies’ Non-randomised comparative studies will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist and statistician, and…
Read more

RWE Live Masterclass 2: ‘The Tyranny of Propensity Scores’ Propensity Scores will be the main topic of the next session of our Real-World Evidence Masterclass Series. This Masterclass mini-series are meant for attendees to learn about perspectives on RWE studies with the help of two experts in this particular field: Professor Stuart Pocock, renewed trialist…
Read more

Real-World Evidence & Trials Masterclass Series 2021  OXON Epidemiology will be hosting a Real-World Evidence Masterclass Series for all professionals interested in learning about the role of Real-World Data studies and their pros and cons compared with trials. Real-World Evidence (RWE) is a key opportunity to better understand the diseases and patient needs. Besides, all…
Read more

OXON will be speaking and exhibiting at World Drug Safety Congress 2019 in Amsterdam on September 10-11, 2019.

Understanding Health Care in Germany is our upcoming webinar. Registration is open for professionals in Pharma companies willing to learn about how to conduct observational studies in this scenario.